Takeaway: This webcast originally aired on February 22, 2021. Replay and transcript excerpts are available below.

In this clip from THE PITCH, we give you an inside look at how a research analyst's high-conviction stock idea becomes a manager's winning position.

Watch below as Healthcare analyst Tom Tobin pitches Hedgeye CEO Keith McCullough on Dario Health (DRIO), Tobin's new 'Best Idea' Long position.  

Click here to learn more about Tom Tobin's "Health Care Pro" Product.

Click here to watch the entire hour long The Pitch, including 5 other analysts' Best Ideas.

. . .

"Dario Health (DRIO) essentially provides a customer (their core customer is diabetics) a little device that helps them keep their tools and kits to measure their blood pressure. It's not fancy at all. But what they have on the backend is an artificial intelligence coach that helps keep people on track.

One of the things that pushed me over the edge has been this "coach" - one of the primary uses of telemedicine going forward will be a tracker like this. In a recent conversation I had with an endocrinologist, they were amazed with Dario's use case and performance with their patients.

The disease management and measurement piece is key.

One of the things that's been going on in the market is that there's a few privately-funded companies that are getting valuations for very similar product-sets and technologies which make Dario look cheap. 

If you look at the multiples now, this thing was left for dead for quite some time. This is a name that's going to get increased coverage from the sell-side and generate a lot of interest.

The stock is only going to go up from here."


Click HERE to for a free Healthcare Sector Pro note: Health Care Morning Brief - Monday Update ($TXG, $AMN, $JNJ, $NSTG, MicroQuads Update)

Click HERE to for a free Healthcare Sector Pro note: Health Care Pro | Weekly Position Monitor Update | For Week of February 22, 2021

. . .

The Call is our morning research call hosted by Hedgeye CEO Keith McCullough with our 40+ analyst research team. It helps small and large investors alike make better decisions via unique and investable stock/sector updates. Click here to learn more.